drugset / Trial / NCT05900661
The Effect of Myo-inositol, Somatropin, and DHEA on Poor Ovarian Responders
RandomizedParallel-groupOpen-labelTreatment
Summary
To evaulate the role of Myo-inositol, somatropin, DHEA on ICSI outcome in poor ovarian responder
Timeline
- Start
- 2023-07-30
- Primary completion
- 2023-09-30
- Completion
- 2023-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DHEA 50 mg twice per day for 12 weeks in the last group , NATROL UK.Ltd. | Unknown | 50 mg | — |
| Subject | Inositol | Small molecule | 600 ug | — |
| Subject | Somatropin | Protein / enzyme biologic | 4 iu | Subcutaneous |
| Subject | folic acid | Other / unclassified | 0.2 mg | — |
Indications
No indication recorded.